New inhaled therapy tested to fight stubborn lung infections in CF
NCT ID NCT06016088
Summary
This study is testing the safety of a new inhaled medication called RSP-1502 for people with cystic fibrosis who have a chronic lung infection called Pseudomonas aeruginosa. Participants will breathe in the medication through a nebulizer for 14 days. The goal is to see if this treatment is safe and to find the right dose for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOMONAS AERUGINOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Augusta University
RECRUITINGAugusta, Georgia, 30912, United States
Contact
Contact Email: •••••@•••••
-
Center for Cystic Fibrosis at Keck Medical Center of USC
RECRUITINGLos Angeles, California, 90033, United States
Contact
Contact Email: •••••@•••••
-
Columbia University Cystic Fibrosis Program
RECRUITINGNew York, New York, 10027, United States
Contact Email: •••••@•••••
Contact
-
Dell Children's Medical Center of Central Texas
RECRUITINGAustin, Texas, 78723, United States
Contact
Contact Email: •••••@•••••
-
Lung Institute of Western Australia
RECRUITINGNedlands, Western Australia, Australia
Contact Email: •••••@•••••
-
Nationwide Children's Hospital
RECRUITINGColumbus, Ohio, 43205, United States
Contact
Contact Email: •••••@•••••
-
Queensland Children's Hospital
RECRUITINGBrisbane, Queensland, Australia
Contact Email: •••••@•••••
-
Rainbow Babies and Children's Hospital / University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Contact Email: •••••@•••••
-
Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, Australia
Contact Email: •••••@•••••
-
Royal Prince Albert Hospital
RECRUITINGCamperdown, New South Wales, Australia
Contact Email: •••••@•••••
-
Stanford University Medical Center
RECRUITINGPalo Alto, California, 94305, United States
Contact
Contact Email: •••••@•••••
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, Australia
Contact Email: •••••@•••••
-
The Cystic Fibrosis Institute
RECRUITINGNorthfield, Illinois, 60093, United States
Contact Email: •••••@•••••
Contact
-
The Kids Research Institute Australia, Perth Children's Hospital
RECRUITINGPerth, Western Australia, Australia
Contact Email: •••••@•••••
-
The Minnesota Cystic Fibrosis Center
RECRUITINGMinneapolis, Minnesota, 55403, United States
Contact
Contact Email: •••••@•••••
-
The Prince Charles Hospital
RECRUITINGBrisbane, Queensland, Australia
Contact Email: •••••@•••••
-
The Royal Children's Hospital
RECRUITINGParkville, Victoria, Australia
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Tucson Cystic Fibrosis Center
RECRUITINGTucson, Arizona, 85750, United States
Contact
Contact Email: •••••@•••••
-
Tulane University
RECRUITINGNew Orleans, Louisiana, 70118, United States
Contact
Contact Email: •••••@•••••
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Contact Email: •••••@•••••
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63130, United States
Contact
Contact Email: •••••@•••••
-
Westmead Hospital
RECRUITINGWestmead, New South Wales, Australia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.